25 results for “Parkinson's Disease”. Showing 25 of 39,449.
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
Parkinson's disease and monogenic Parkinson's disease. We used
Lipid pathway dysfunction is prevalent in patients with Parkinson's disease.
Parkinson's disease. Moreover, the hallmark Parkinson's disease pathological
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
Parkinson's disease individuals with normal cognition, 121 Parkinson's disease
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Parkinson's disease patients. Moreover, nigral idiopathic Parkinson's disease
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
Parkinson's disease is a progressive neurodegenerative disorder with multifactorial
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Parkinson's disease. Clinically, Parkinson's disease patients with GBA mutations
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
diseases, a particularly crucial point as the Parkinson's disease
Parkinson's disease - genetic cause.
Parkinson's disease. Majority of Parkinson's disease is genetically
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Parkinson's disease from healthy controls. We used the well
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Parkinson's disease cases, 13 431 Parkinson's disease proxy
Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
Parkinson's disease, persists with disease progression and in combination
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Parkinson's disease have increased the scope of biological knowledge
Large-scale rare variant burden testing in Parkinson's disease.
Parkinson's disease has a large heritable component and genome
Gut-brain axis and environmental factors in Parkinson's disease: bidirectional link between disease onset and progression.
Parkinson's disease patients, suggesting a potential role in disease
The pathogenesis of Parkinson's disease.
Parkinson's disease. Although there are currently no disease-modifying
LRRK2 and Proteostasis in Parkinson's Disease.
disease. Although different gene variants are linked to Parkinson disease
Impaired dopamine release in Parkinson's disease.
Parkinson's disease is the second most common neurodegenerative disease
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
disease, are also potent risk factors for Parkinson's disease
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.
Parkinson's disease. Their application in Parkinson's disease diagnosis
Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.
Parkinson's disease, we performed a case-control study in two regions
CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy.
diseases, the clinical significance of circRNAs in dopaminergic (DA) neuronal degeneration in the pathogenesis of Parkinson
The role of chaperones in Parkinson's disease and prion diseases.
disease, Parkinson's disease, polyglutamine diseases, or prion diseases may be diverse
Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.
disease-slowing or preventative treatment. Recent conceptualizations of Parkinson's disease
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
Parkinson's disease; however, individuals with Parkinson's disease are often
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations.
Parkinson disease without GBA mutations; PD: Parkinson disease; PINK1: PTEN